CVS HEALTH Corp
CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/3014% above fair value
$88.51−1.74 (-1.93%)
Close on Nov 2, 2026Market cap $113.20BP/E 23.5Yield 3.01%
Cvs Health Allowance for Credit Losses on Accounts Receivable by Year
Allowance for Credit Losses on Accounts Receivable ($M)
Cvs Health Allowance for Credit Losses on Accounts Receivable: $182M in FY2025, down 55.3% from a year earlier.
Latest, FY2025
182
Period ended Dec 31, 2025
Change on a year earlier
-55.3%
407 in FY2024
History
10 years
Since FY2016
Sources
2
Documents cited below
Where the FY2025 figure comes from
Source: CVS SEC 10-Q (XBRL us-gaap:AllowanceForDoubtfulAccountsReceivable) ↗
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Cvs Health Allowance for Credit Losses on Accounts Receivable ($M), annual FY2016–FY2025 [Data set]. Compiled from Cvs Health SEC filings and investor materials. https://stockdatahq.com/stocks/cvs/kpis/ar-allowance
See every metric in the Cvs Health KPI table. Data updated Oct 28, 2026.